Genesys International Corporation Limited (NSE:GENESYS)
India · Delayed Price · Currency is INR 317.40
-6.15 (-1.90%)
Feb 19, 2026, 2:10 PM IST
NSE:GENESYS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 3,178 | 3,110 | 1,982 | 1,811 | 1,196 | 795.59 |
Revenue | 3,178 | 3,110 | 1,982 | 1,811 | 1,196 | 795.59 |
Revenue Growth (YoY) | 10.32% | 56.89% | 9.45% | 51.41% | 50.37% | -28.83% |
Cost of Revenue | 1,591 | 1,417 | 994.53 | 1,037 | 809.18 | 642.97 |
Gross Profit | 1,586 | 1,693 | 987.9 | 773.96 | 387.11 | 152.62 |
Selling, General & Admin | 11.71 | 11.71 | 1.24 | 3.31 | 6.53 | 8.69 |
Other Operating Expenses | 324.27 | 259.84 | 181.27 | 186.94 | 105.64 | 144.86 |
Operating Expenses | 967.44 | 821.83 | 627.31 | 562.33 | 303.43 | 341.2 |
Operating Income | 618.71 | 871.01 | 360.59 | 211.63 | 83.68 | -188.59 |
Interest Expense | -122.06 | -87.8 | -39.09 | -26.66 | -24.78 | -38.87 |
Interest & Investment Income | 19.22 | 19.22 | 8.76 | 3.84 | 3.08 | 1.62 |
Currency Exchange Gain (Loss) | 22.7 | 22.7 | 6.85 | 31.44 | 14.58 | 0.78 |
Other Non Operating Income (Expenses) | 121.38 | 1.45 | 22.06 | 5.72 | 14.58 | 4.61 |
EBT Excluding Unusual Items | 659.95 | 826.57 | 359.16 | 225.97 | 91.15 | -220.45 |
Gain (Loss) on Sale of Investments | - | - | 11.05 | 23.97 | 1.24 | -12.41 |
Gain (Loss) on Sale of Assets | 0.2 | 0.2 | 1.55 | 0.02 | - | 0.53 |
Other Unusual Items | -50.96 | - | - | - | -451.07 | -312.1 |
Pretax Income | 609.18 | 826.76 | 371.76 | 249.96 | -358.69 | -544.44 |
Income Tax Expense | 218.43 | 265.73 | 155.63 | 100.64 | 38.17 | -26.55 |
Earnings From Continuing Operations | 390.75 | 561.04 | 216.12 | 149.32 | -396.85 | -517.88 |
Minority Interest in Earnings | 0.85 | 1.2 | 4.61 | 41.46 | 530.97 | 88.56 |
Net Income | 391.6 | 562.23 | 220.73 | 190.78 | 134.12 | -429.32 |
Net Income to Common | 391.6 | 562.23 | 220.73 | 190.78 | 134.12 | -429.32 |
Net Income Growth | -24.87% | 154.72% | 15.70% | 42.25% | - | - |
Shares Outstanding (Basic) | 41 | 40 | 38 | 35 | 31 | 31 |
Shares Outstanding (Diluted) | 41 | 40 | 38 | 36 | 34 | 31 |
Shares Change (YoY) | 2.27% | 4.03% | 6.28% | 7.32% | 8.11% | -0.60% |
EPS (Basic) | 9.54 | 14.17 | 5.78 | 5.43 | 4.29 | -13.77 |
EPS (Diluted) | 9.52 | 14.06 | 5.74 | 5.29 | 4.01 | -13.77 |
EPS Growth | -26.52% | 144.95% | 8.51% | 32.05% | - | - |
Free Cash Flow | - | -963.16 | -543.79 | -1,204 | 91.47 | 109.54 |
Free Cash Flow Per Share | - | -24.08 | -14.14 | -33.28 | 2.71 | 3.51 |
Gross Margin | 49.92% | 54.43% | 49.83% | 42.73% | 32.36% | 19.18% |
Operating Margin | 19.47% | 28.00% | 18.19% | 11.68% | 7.00% | -23.70% |
Profit Margin | 12.32% | 18.08% | 11.13% | 10.53% | 11.21% | -53.96% |
Free Cash Flow Margin | - | -30.97% | -27.43% | -66.46% | 7.65% | 13.77% |
EBITDA | 1,107 | 1,307 | 727.75 | 534.08 | 233.63 | -37.75 |
EBITDA Margin | 34.82% | 42.02% | 36.71% | 29.49% | 19.53% | -4.74% |
D&A For EBITDA | 487.8 | 436.1 | 367.16 | 322.46 | 149.95 | 150.84 |
EBIT | 618.71 | 871.01 | 360.59 | 211.63 | 83.68 | -188.59 |
EBIT Margin | 19.47% | 28.00% | 18.19% | 11.68% | 7.00% | -23.70% |
Effective Tax Rate | 35.86% | 32.14% | 41.86% | 40.26% | - | - |
Revenue as Reported | 3,341 | 3,154 | 2,033 | 1,876 | 1,230 | 807.19 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.